Angioplasty laser to be sold in Europe:
This article was originally published in Clinica
Spectranetics has CE-marked its latest angioplasty catheter which is designed to create larger channels in blocked coronary arteries than the currently available Vitesse C device. The Colorado Springs-based company submitted a premarketing approval application for the new Vitesse COS device in the US in August.
You may also be interested in...
The national regulator is to undergo a review in 2021 as the UK begins life as a former EU member, presenting opportunities to be seized.
Policy experts predicted how the incoming Biden administration will handle health care issues at a recent Alliance for Health Policy webinar. Rachel Nuzum, VP of state and federal policy at The Commonwealth Fund, said telehealth could be a priority.
The China National Biotec Group has filed the first application in China for the broad use of a COVID-19 vaccine, days after the national regulatory agency released review guidelines for the conditional approval of such products.